1. Home
  2. REPL vs EIM Comparison

REPL vs EIM Comparison

Compare REPL & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • EIM
  • Stock Information
  • Founded
  • REPL 2015
  • EIM 2002
  • Country
  • REPL United States
  • EIM United States
  • Employees
  • REPL N/A
  • EIM N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • EIM Finance/Investors Services
  • Sector
  • REPL Health Care
  • EIM Finance
  • Exchange
  • REPL Nasdaq
  • EIM Nasdaq
  • Market Cap
  • REPL 547.0M
  • EIM 561.3M
  • IPO Year
  • REPL 2018
  • EIM N/A
  • Fundamental
  • Price
  • REPL $5.80
  • EIM $10.04
  • Analyst Decision
  • REPL Hold
  • EIM
  • Analyst Count
  • REPL 9
  • EIM 0
  • Target Price
  • REPL $7.00
  • EIM N/A
  • AVG Volume (30 Days)
  • REPL 2.5M
  • EIM 215.2K
  • Earning Date
  • REPL 11-11-2025
  • EIM 01-01-0001
  • Dividend Yield
  • REPL N/A
  • EIM 4.32%
  • EPS Growth
  • REPL N/A
  • EIM N/A
  • EPS
  • REPL N/A
  • EIM N/A
  • Revenue
  • REPL N/A
  • EIM N/A
  • Revenue This Year
  • REPL N/A
  • EIM N/A
  • Revenue Next Year
  • REPL $408.25
  • EIM N/A
  • P/E Ratio
  • REPL N/A
  • EIM N/A
  • Revenue Growth
  • REPL N/A
  • EIM N/A
  • 52 Week Low
  • REPL $2.68
  • EIM $8.61
  • 52 Week High
  • REPL $17.00
  • EIM $10.51
  • Technical
  • Relative Strength Index (RSI)
  • REPL 47.90
  • EIM 58.26
  • Support Level
  • REPL $5.74
  • EIM $9.73
  • Resistance Level
  • REPL $6.15
  • EIM $10.54
  • Average True Range (ATR)
  • REPL 0.35
  • EIM 0.16
  • MACD
  • REPL 0.12
  • EIM 0.03
  • Stochastic Oscillator
  • REPL 41.03
  • EIM 39.51

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About EIM Eaton Vance Municipal Bond

Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.

Share on Social Networks: